Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 26, 1165-1169, June 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cooper, M. D.
Right arrow Articles by Good, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cooper, M. D.
Right arrow Articles by Good, R. A.

Lymphoid Malignancy and Development, Differentiation, and Function of the Lymphoreticular System1

Max D. Cooper2, Raymond D. A. Peterson3, Ann E. Gabrielsen4 and Robert A. Good5

Department of Pediatrics, University of Minnesota School of Medicine, Minneapolis, Minnesota

There are 2 pathways of normal lymphoid differentiation. The thymus is responsible for initiation and control of cellular differentiation directed toward the small lymphocyte and cellular immunity. The avian bursa of Fabricius, and perhaps Peyer's patches of man, initiates and controls another lymphoid differentiation pathway directed toward the plasma cell and immunoglobulin production. Thymus-dependent and bursa-dependent lymphocytic malignancies have been defined in the mouse and chicken, respectively, and are featured by abnormal lymphoid differentiation beginning in one or the other central lymphoid organ. It is proposed that clinical lymphoid malignancies may also be usefully classified as either thymus system or immunoglobulin-producing system malignancies. In this view Hodgkin's disease appears to be a thymus system disease, and more focused study of its central organ seems indicated.

1 Aided by grants from the USPHS (HE-02085, AI-00798, NB-02042), the American Cancer Society, the American Heart Association, and the National Foundation.

2 Postdoctoral Research Fellow, USPHS.

3 Established Investigator, American Heart Association.

4 Research Fellow, USPHS. Grant 9T1-AI292.

5 American Legion Memorial Heart Research Professor of Pediatrics and Microbiology.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1966 by the American Association for Cancer Research.